These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 17709148

  • 1. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM, Park KD, Lee KH, Byun YH, Park JH, Kim SH, Kim JH, Seong BL.
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [Abstract] [Full Text] [Related]

  • 2. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M, Yang F, Zhou W, Liu A, Du G, Zheng L.
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
    Yamada K, Ogawa H, Hara A, Yoshida Y, Yonezawa Y, Karibe K, Nghia VB, Yoshimura H, Yamamoto Y, Yamada M, Nakamura K, Imai K.
    Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA, Bovin NV, Webster RG, Govorkova EA.
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [Abstract] [Full Text] [Related]

  • 8. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K, Richter M, Wutzler P, Schmidtke M.
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
    Bai GR, Chittaganpitch M, Kanai Y, Li YG, Auwanit W, Ikuta K, Sawanpanyalert P.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):897-901. PubMed ID: 19850010
    [Abstract] [Full Text] [Related]

  • 12. Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
    Bauer K, Schrader C, Suess J, Wutzler P, Schmidtke M.
    Antiviral Res; 2007 Sep 18; 75(3):219-26. PubMed ID: 17445913
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y, Narayanan S, Chang KO.
    Antiviral Res; 2010 Nov 18; 88(2):227-35. PubMed ID: 20826184
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K.
    J Med Chem; 2012 Mar 08; 55(5):2144-53. PubMed ID: 22332894
    [Abstract] [Full Text] [Related]

  • 15. Germacrone inhibits early stages of influenza virus infection.
    Liao Q, Qian Z, Liu R, An L, Chen X.
    Antiviral Res; 2013 Dec 08; 100(3):578-88. PubMed ID: 24095670
    [Abstract] [Full Text] [Related]

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M, Liu A, Du G, Naesens L, Vanderlinden E, De Clercq E, Liu X.
    Chem Biol Drug Des; 2011 Oct 08; 78(4):596-602. PubMed ID: 21752202
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O, Kessler N, Lina B.
    Antiviral Res; 2005 Oct 08; 68(1):43-8. PubMed ID: 16125799
    [Abstract] [Full Text] [Related]

  • 18. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y, Nehmé B, Baz M, Boivin G.
    Antiviral Res; 2008 Feb 08; 77(2):163-6. PubMed ID: 17919743
    [Abstract] [Full Text] [Related]

  • 19. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A.
    Antiviral Res; 2009 Sep 08; 83(3):290-7. PubMed ID: 19591877
    [Abstract] [Full Text] [Related]

  • 20. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.
    Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.